SBUX
29
-2
CVS
27
2
PHM
44
4
EXR
42
5
CMCSA
49
3
NTRS
35
10
XRX
48
2
MSI
52
3
CF
47
5
SO
48
6
IVZ
42
13
HIG
48
5
PFE
37
4
AA
27
5
SCHW
40
3
MCO
67
3
D
32
10
CNP
59
17
CRM
65
6
NEE
39
9
SBUX
29
-2
CVS
27
2
PHM
44
4
EXR
42
5
CMCSA
49
3
NTRS
35
10
XRX
48
2
MSI
52
3
CF
47
5
SO
48
6
IVZ
42
13
HIG
48
5
PFE
37
4
AA
27
5
SCHW
40
3
MCO
67
3
D
32
10
CNP
59
17
CRM
65
6
NEE
39
9
Financhill
Back

ProPhase Labs Vs. Nukkleus Industry Stock Comparison

Sell
10

PRPH
ProPhase Labs

Last Price:
$0.63
Seasonality Move:
15.03%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
10
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.61. The Score for PRPH is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 24.33 Sell
Chaikin Money Flow: -319202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.67 - 0.77) Sell
Bollinger Bands (100): (1.12 - 2.76) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Sell
20-day SMA: 0.71 Sell
50-day SMA: 1.34 Sell
200-day SMA: 3.4 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.77 Sell
50-day EMA: 1.23 Sell
200-day EMA: 2.93 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):